SEARCH HEALTH CONDITIONS BY ALPHABETS
Nail Dystrophy
Medications for Nail Dystrophy
About Nail Dystrophy: Nail Dystrophy is a change in texture or composition of their finger or toe nails. This is sometimes brought on by injury, fungal disease, psoriasis, lichen planus and also many different causes.
Drugs Used to Treat Nail Dystrophy
This list of medications have been in some way associated with, or used at the treating this particular condition.
| Medication name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| poly-ureaurethane | Rx | U | Insert review | 0.0 | |||
Generic title: poly-ureaurethane topical For consumers: For professionals: a z Drug Facts | |||||||
Legend
| Rx | prescription-only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Off Label | This medication may not be approved by the FDA for the treatment of this particular condition. |
| Pregnancy Category | |
|---|---|
| A | Adequate and well-controlled studies have failed to present a risk to the embryo within the first trimester of pregnancy (also there isn`t any evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in elderly women. |
| C | Animal research studies have shown an adverse effect on the fetus and there are no sufficient and well-controlled studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in elderly women clearly outweigh potential rewards. |
| N | FDA has not classified the medication. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| Inch | includes a higher potential for abuse. Has no accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
| 2 | includes a higher potential for abuse. Features a currently accepted medical use with severe restrictions or a currently accepted medical use in treatment in the United States. Abuse may result in severe emotional or physical dependency. |
| 3 | includes a potential for abuse less than those in schedules 1 and two. Features a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | includes a very low potential for abuse relative to those in schedule 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
| 5 | includes a very low potential for abuse relative to those in schedule 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
| Alcohol | |
|---|---|
| X | Interacts with Medication. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Frazee
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask with your physician to ensure the information displayed on this page applies to your circumstances.
Top USA Pharma Companies
Product Categories
Popular Categories
Health Condition
Easily find an affordable health insurance plan
